Infection-related hospitalization in childhood and adult metabolic outcomes

Pediatrics

Volumn 136, Issue 3, 2015, Pages e554-e562

  Burgner, David P ^a,b,c   Sabin, Matthew A ^a,b,d   Magnussen, Costan G ^e,f   Cheung, Michael ^a,b,d   Kähönen, Mika ^g   Lehtimäki, Terho ^h   Hutri Kähönen, Nina ⁱ   Jokinen, Eero ^j   Laitinen, Tomi ^k   Taittonen, Leena ^l   Tossavainen, Päivi ^m   Dwyer, Terence ⁿ   Viikari, Jorma S A ^o   Raitakari, Olli T ^e,p   Juonala, Markus ^a,o  

^a MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d ROYAL CHILDREN'S HOSPITAL   (Australia)

^e UNIVERSITY OF TURKU   (Finland)

^f UNIVERSITY OF TASMANIA   (Australia)

^g Department of Clinical Physiology ^*  (Finland)

^h TAMPERE UNIVERSITY HOSPITAL   (Finland)

ⁱ TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^j UNIVERSITY OF HELSINKI   (Finland)

^k KUOPIO UNIVERSITY HOSPITAL   (Finland)

^l UNIVERSITY OF OULU   (Finland)

^m VAASA CENTRAL HOSPITAL   (Finland)

ⁿ OULU UNIVERSITY HOSPITAL   (Finland)

^o UNIVERSITY OF OXFORD   (United Kingdom)

^p TURKU UNIVERSITY HOSPITAL   (Finland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGE; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CARDIOMETABOLIC RISK; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; HYPERTENSION; INCOME; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEX DIFFERENCE; SOCIAL STATUS; WAIST CIRCUMFERENCE; YOUNG ADULT; COMMUNICABLE DISEASES; CROSS-SECTIONAL STUDY; FINLAND; FOLLOW UP; METABOLISM; MIDDLE AGED; TRENDS;

ADOLESCENT; ADULT; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COMMUNICABLE DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; FINLAND; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; LONGITUDINAL STUDIES; MALE; METABOLIC SYNDROME X; MIDDLE AGED;

EID: 84940855704     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2015-0825     Document Type: Article

References (40)

1. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11): e442
2. Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9945):766-781
3. Haffner SM. The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol. 2006;97(2A):3A-11A
4. Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature. 2011; 473(7347):317-325
5. Dinarello CA, van der Meer JW. Treating inflammation by blocking interleukin-1 in humans. Semin Immunol. 2013;25(6): 469-484
6. Juonala M, Juhola J, Magnussen CG, et al. Childhood environmental and genetic predictors of adulthood obesity: the Cardiovascular Risk in Young Finns Study. J Clin Endocrinol Metab. 2011; 96(9):E1542-E1549
7. Carville KS, Lehmann D, Hall G, et al. Infection is the major component of the disease burden in aboriginal and non-aboriginal Australian children: a population-based study. Pediatr Infect Dis J. 2007;26(3):210-216
8. Yorita KL, Holman RC, Sejvar JJ, Steiner CA, Schonberger LB. Infectious disease hospitalizations among infants in the United States. Pediatrics. 2008;121(2): 244-252
9. Christensen KL, Holman RC, Steiner CA, Sejvar JJ, Stoll BJ, Schonberger LB. Infectious disease hospitalizations in the United States. Clin Infect Dis. 2009;49(7): 1025-1035
10. Espinola-Klein C, Rupprecht HJ, Blankenberg S, et al. Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation. 2002;105(1):15-21
11. Leinonen M, Saikku P. Evidence for infectious agents in cardiovascular disease and atherosclerosis. Lancet Infect Dis. 2002;2(1):11-17
12. Pessi T, Karhunen V, Karjalainen PP, et al. Bacterial signatures in thrombus aspirates of patients with myocardial infarction. Circulation. 2013;127(11): 1219-1228, e1211-e1216
13. Schooling CM, Jones HE, Leung GM. Lifecourse infectious origins of sexual inequalities in central adiposity. Int J Epidemiol. 2011;40(6):1556-1564
14. McEniry M, Palloni A, Davila AL, Gurucharri AG. Early life exposure to poor nutrition and infectious diseases and its effects on the health of older Puerto Rican adults. J Gerontol B Psychol Sci Soc Sci. 2008;63(6): S337-S348
15. Shang Q, Wang H, Song Y, et al. Serological data analyses show that adenovirus 36 infection is associated with obesity: a meta-analysis involving 5739 subjects. Obesity (Silver Spring). 2014;22(3):895-900
16. Cox LM, Blaser MJ. Antibiotics in early life and obesity. Nat Rev Endocrinol. 2015;11(3):182-190
17. Elkind MS, Luna JM, Moon YP, et al. Infectious burden and carotid plaque thickness: the Northern Manhattan Study. Stroke. 2010;41(3):e117-e122
18. Raitakari OT, Juonala M, Ronnemaa T, et al. Cohort profile: the Cardiovascular Risk in Young Finns Study. Int J Epidemiol. 2008;37(6):1220-1226
19. Juonala M, Viikari JS, Ronnemaa T, Taittonen L, Marniemi J, Raitakari OT. Childhood C-reactive protein in predicting CRP and carotid intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. Arterioscler Thromb Vasc Biol. 2006;26(8):1883-1888
20. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009; 120(16):1640-1645
21. Cocoros NM, Lash TL, Norgaard M, Farkas DK, DeMaria A Jr, Sorensen HT. Hospitalized prenatal and childhood infections and obesity in Danish male conscripts. Ann Epidemiol. 2013;23(6): 307-313
22. Blaser M. Antibiotic overuse: stop the killing of beneficial bacteria. Nature. 2011;476(7361):393-394
23. Devaraj S, Hemarajata P, Versalovic J. The human gut microbiome and body metabolism: implications for obesity and diabetes. Clin Chem. 2013;59(4):617-628
24. Cox LM, Yamanishi S, Sohn J, et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell. 2014;158(4):705-721
25. Yamada T, Hara K, Kadowaki T. Association of adenovirus 36 infection with obesity and metabolic markers in humans: a meta-analysis of observational studies. PLoS ONE. 2012; 7(7):e42031
26. Kang YS, Cha JJ, Hyun YY, Cha DR. Novel C-C chemokine receptor 2 antagonists in metabolic disease: a review of recent developments. Expert Opin Investig Drugs. 2011;20(6):745-756
27. Hegde V, Dhurandhar NV. Microbes and obesity-interrelationship between infection, adipose tissue and the immune system. Clin Microbiol Infect. 2013;19(4): 314-320
28. Fernandez-Real JM, Ferri MJ, Vendrell J, Ricart W. Burden of infection and fat mass in healthy middle-aged men. Obesity (Silver Spring). 2007;15(1): 245-252
29. Fernandez-Real JM, Lopez-Bermejo A, Vendrell J, Ferri MJ, Recasens M, Ricart W. Burden of infection and insulin resistance in healthy middle-aged men. Diabetes Care. 2006;29(5):1058-1064
30. Zhu J, Nieto FJ, Horne BD, Anderson JL, Muhlestein JB, Epstein SE. Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation. 2001;103(1):45-51
31. Zhu J, Quyyumi AA, Norman JE, et al. Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. Am J Cardiol. 2000;85(2):140-146
32. Burgner D, Jamieson SE, Blackwell JM. Genetic susceptibility to infectious diseases: big is beautiful, but will bigger be even better? Lancet Infect Dis. 2006; 6(10):653-663
33. van de Weg CA, Koraka P, van Gorp EC, et al. Lipopolysaccharide levels are elevated in dengue virus infected patients and correlate with disease severity. J Clin Virol. 2012;53(1):38-42
34. Lassenius MI, Pietilainen KH, Kaartinen K, et al. Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation. Diabetes Care. 2011;34(8):1809-1815
35. Fejer G, Szalay K, Gyory I, et al. Adenovirus infection dramatically augments lipopolysaccharide-induced TNF production and sensitizes to lethal shock. J Immunol. 2005;175(3): 1498-1506
36. Nativel B, Marimoutou M, Thon-Hon VG, et al. Soluble HMGB1 is a novel adipokine stimulating IL-6 secretion through RAGE receptor in SW872 preadipocyte cell line: contribution to chronic inflammation in fat tissue. PLoS ONE. 2013;8(9):e76039
37. Nakagomi A, Sasaki M, Ishikawa Y, et al. Upregulation of monocyte tissue factor activity is significantly associated with low-grade chronic inflammation and insulin resistance in patients with metabolic syndrome. Circ J. 2010;74(3): 572-577
38. Carvalheira JB, Qiu Y, Chawla A. Blood spotlight on leukocytes and obesity. Blood. 2013;122(19):3263-3267
39. Trasande L, Blustein J, Liu M, Corwin E, Cox LM, Blaser MJ. Infant antibiotic exposures and early-life body mass. Int J Obes (Lond). 2013;37(1):16-23
40. Saxena S, Majeed A, Jones M. Socioeconomic differences in childhood consultation rates in general practice in England and Wales: prospective cohort study. BMJ. 1999; 318(7184):642-646